Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2013

Conditions
Carcinoma, Hepatocellular
Interventions
DEVICE

Ablation with the NanoKnife Low Energy Direct Current (LEDC) System

90 pulses of 70 microseconds each in duration will be administered per electrode pair.

Trial Locations (6)

56124

University of Pisa School of Medicine, Pisa

80131

Istituto Nazionale Tumori - Fondazione Pascale, Naples

92110

Hopital Beaujon, Paris

94805

L'institut de cancerologie Gustave Roussy, Villejuif

D-39120

Universitatsklinikum Magdeburg AoR, Klinik fur Radiologie und Nuklearmedizin, Magdeburg

08036

Barcelona Clinic Liver Cancer Group, Hospital Clinic i Provincial de Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

Angiodynamics, Inc.

INDUSTRY